Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE‐AF study.

Patients with atrial fibrillation (AF) are at an approximately 0.5% to 3% increased risk of thromboembolism during and immediately after catheter ablation. Treatment guidelines recommend periprocedural oral anticoagulation plus unfractionated heparin during ablation. Rivaroxaban and dabigatran are t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Hohnloser, Stefan H., Camm, John, Cappato, Riccardo, Diener, Hans‐Christoph, Heidbuchel, Hein, Lanz, Hans‐Joachim, Mont, Lluís, Morillo, Carlos A., Smolnik, Rüdiger, Yin, Ophelia Q.P., Kautzner, Josef
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2018
Assuntos:
Trial Designs
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489708/
https://ncbi.nlm.nih.gov/pubmed/29663464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22918
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados